APIOC for Presbyopia and APIOC for Presbyopia With Astigmatism

January 17, 2022 updated by: Lentechs, LLC

7 Day Trial of APIOC for Presbyopia and APIOC for Presbyopia With Astigmatism

Vision and comfort, both objective and subjective, will be assessed for single vision contact lens wearers for either the APIOC™ for Presbyopia or the APIOC™ for Presbyopia Astigmatism contact lenses.

Study Overview

Study Type

Interventional

Enrollment (Actual)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • San Diego, California, United States, 92123
        • Complete Family Vision Care
    • Florida
      • Orlando, Florida, United States, 32803
        • Eola Eyes
    • Kentucky
      • Lexington, Kentucky, United States, 40517
        • Gaddie Eye Centers
    • Ohio
      • Miamisburg, Ohio, United States, 45342
        • Miamisburg Vision Care
      • New Albany, Ohio, United States, 43054
        • Vision Professionals
      • Powell, Ohio, United States, 43065
        • EyeCare Professionals of Powell

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. The subject must provide written informed consent.
  2. The subject must appear willing and able to adhere to the instructions set forth in this protocol.
  3. At least 40 years of age and no more than 70 years of age.
  4. ≤ 4.00 D of corneal astigmatism.
  5. ≤ 2.50 D of refractive astigmatism.
  6. Refractive error range +4.00 DS to -6.00 DS
  7. Require a reading addition (bifocal) of at least 0.75 D
  8. Flat and steep keratometry readings within 40 to 48 D.
  9. Clear, healthy corneas with no irregular astigmatism.
  10. Normal, healthy conjunctiva in both eyes.
  11. Free of active ocular disease. Refractive error and presbyopia are permitted.
  12. Be a current or former (within the last 3 years) contact lens wearer.
  13. Best-corrected near and distance visual acuity better than or equal to 20/25.

Exclusion Criteria:

  1. Irregular corneal astigmatism.
  2. Corneal scarring unless off line-of-site and well healed.
  3. Pinguecula, pterygium, or other conjunctival thickness abnormalities that would interfere with soft contact lens wear.
  4. Recent use of any ocular pharmaceutical treatments, including daily artificial tears, in the two weeks prior to the examination. Occasional artificial tear use is permitted.
  5. Systemic disease that would interfere with contact lens wear.
  6. Currently pregnant or lactating (by self-report).
  7. History of strabismus or eye movement disorder, including exophoria at near that is 4 D or greater than at far, and a receded near point of convergence break that is 6 cm or greater.
  8. Active allergies that may inhibit contact lens wear.
  9. Upper eyelid margin at or above the superior limbus.
  10. History of ocular or lid surgery.
  11. Immediate family members or significant others of doctors or staff at the clinical site.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: APIOC for Presbyopia and Presbyopia with Astigmatism
Presbyopic Spherical or Toric Contact Lens
Contact Lenses for Presbyopia

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual Acuity Distance
Time Frame: Day 7
High and Low Contrast LogMAR
Day 7
Subjective Vision Quality
Time Frame: Day 7
Visual analogue scale (0-100 points) 100 is best possible quality of vision
Day 7
Comfort
Time Frame: Day 7
Visual analogue scale(0-100 points) 100 is best possible comfort
Day 7
Visual Acuity Near
Time Frame: Day 7
High and Low Contrast
Day 7
Visual Acuity Intermediate
Time Frame: Day 7
High and Low Contrast
Day 7

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Subjective Comfort
Time Frame: Day 7
Compared to habitual lenses, rated as better/same/worse
Day 7
Subjective vision Comparison
Time Frame: Day 7
Compared to habitual lenses, rated as better/same/worse
Day 7

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Thomas Quinn, OD, MS, Athens Eye Care

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 6, 2021

Primary Completion (Actual)

October 31, 2021

Study Completion (Actual)

October 31, 2021

Study Registration Dates

First Submitted

May 4, 2021

First Submitted That Met QC Criteria

May 6, 2021

First Posted (Actual)

May 12, 2021

Study Record Updates

Last Update Posted (Actual)

January 19, 2022

Last Update Submitted That Met QC Criteria

January 17, 2022

Last Verified

January 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • LEN101

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

No sharing of data is planned.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Presbyopia

Clinical Trials on APIOC for Presbyopia and APIOC for Presbyopia for Astigmatism

3
Subscribe